PCN113 Cost-Utility Analysis of Combination Therapy of Pegylated Liposomal Doxorubicin(PLD) and Carboplatin for Korean Women with Platinum-Sensitive Ovarian Cancer

Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.1214
https://www.valueinhealthjournal.com/article/S1098-3015(11)02776-8/fulltext
Section Title : Cancer
Section Order : 1172
First Page : A455
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02776-8&doi=10.1016/j.jval.2011.08.1214
HEOR Topics :
Tags :
Regions :